IS HRT SAFE? Rosol Hamid Consultant O&G. NO What is safe? Driving Swimming Crossing the street Cycling Riding a motor bike Parachute jumping Flying.

Slides:



Advertisements
Similar presentations
Menopause in Women With IBD. Menopause Natural menopause results from gradual decline in number of estradiol-producing ovarian follicles Natural menopause.
Advertisements

Contraception in the over 40’s
2006 : TERAPIA ORMONALE SOSTITUTIVA DELLA MENOPAUSA
for Bio-Identical Hormones
Hormone Replacement Therapy. 6/11/2014 OB-GYN Specialists, PC and Covenant Medical Center Hormonal Therapy Beliefs before July 2002 Relieves hot flashes,
HORMONE REPLACEMENT, AN OVERVIEW DR SARAH WHITFIELD.
Menopause Lisa Keller, M.D.. Menopause Basics By 2010, 45% of American women will be over age 50.
What’s new in menopause management? Associate Professor John Eden School of Women’s & Children’s Health Providing Care in Partnership with Women.
Menopause and HRT. AIMS Menopause : How to diagnosis Symptoms Treatments Premature menopause HRT : indications/contraindications.
© 2013 North American Menopause Society. Menopause. 2013;20(9): Key points from the 2013 Position Statement of The North American Menopause Society.
Women’s Health Initiative - Summary of results DISCLAIMER Menopausetoday gives the following presentation for your information and.
Tailoring HRT to the patient Dr Bruce Davies To insert your company logo on this slide From the Insert Menu Select “Picture” Locate your logo file Click.
Hormone Replacement Therapy Dr Belinda Magnus. Menopause - Background  Vasomotor symptoms affect around 80% women during the menopause – severe in 20%
HRT In a nutshell for all the blokes out there. diagnosis  Clinical hx  FSH limited value as levels fluctuate  May be of value in symtomatic women.
The Affect Common Chemicals May Have on Women’s Hormone Therapy Presented By: Sean Snowden.
M ENOPAUSE Phil Thirkell. D EFINE THE MENOPAUSE [2 MARKS ] No menstrual periods for 12 months.
Hormone Replacement Therapy
Chapter 61 Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications 1.
Cardiovascular Disease in Women Module VI: Update on Menopausal Hormone Therapy and Selective Estrogen Receptor Modulators (SERMs)
The statement was published in the journals of The North American Menopause Society (Menopause), the American Society for Reproductive Medicine (Fertility.
MENOPAUSE Dr. Malak Al Hakeem Prof. of Gynaecology & Obstetrics.
To treat or not to treat? Highly individualized. Debilitating symptoms. Mild symptoms.
Sex, Menopause, and Aging
Menopause. What is Menopause? The end of a woman’s menstrual cycle.
Hormonal Replacement Therapy for postmenopausal females: To give or not to give? Amna B. Buttar, MD, MS Assistant Professor of Clinical Medicine Indiana.
M E N O P A U S E King Khalid University Hospital Department of Obstetrics & Gynecology Course 481.
Hormone Replacement Therapy 5/11/07 5/11/07Tanu. History of HRT Approximately 100years of research and 80 years of clinical practice Ovarian extracts.
Aging and Obesity Claire Zizza Tenth Annual Diabetes and Obesity Conference April 19, 2011.
The BMS Recommendations “ A blueprint for preventing and managing the problems of the menopause” Nick Panay Immediate Past Chairman, BMS Consultant Gynaecologist,
MANAGING THE MENOPAUSE SUMMARY HRT appropriate for moderate to severe symptoms HRT appropriate for moderate to severe symptoms HRT should not be.
Seminar 5 Eugene de Silva Ph.D. FRSA. Introduction Welcome Welcome SC300 AU Course – Unit 5 – week 5 SC300 AU Course – Unit 5 – week 5 Discussion points.
How to survive your menopause David Griffiths Consultant Gynaecologist Christine Pearce Consultant Nurse 3 rd Sept 2014.
Family medicine Common problems in Obstetric and Gynaecology.
Seminar 5 Eugene de Silva Ph.D. FRSA. Introduction Welcome Welcome SC300 AU Course – Unit 5 – week 5 SC300 AU Course – Unit 5 – week 5 Discussion points.
Breast Cancer Risk with Menopausal Hormone Use Jackie Bouillon Advisor: Dr. Robert Hadley Spring 2007.
MacLennan Selected Risks and Benefits after 5 Years of combined estrogen and progestogen HRT for all women aged (WHI Study, 2002) OESTROGEN WITH.
Personal Risk Factors Gender being a woman is the main risk factor for developing breast cancer (100 times more common in women) Age occurrence increase.
Hormone replacement therapy: practical considerations Marco Gambacciani and Nick Panay.
MENAPOUSE. Natural Surgical premature RETROSPECTIVE Cessation of menstruation for 12 months In the absence of other physiological or psychological.
Menopausal Hormone Replacement Professor Gordana Prelevic, MD, DSc, FRCP Consultant Endocrinologist Royal Free Hampstead NHS Trust Whittington Health.
Please feel free to chat amongst yourselves until we begin at the top of the hour.
Menopause Case Study. VETERANS HEALTH ADMINISTRATION Case Study Marion, a 52-year-old female veteran, presents to your office for evaluation of hot flashes.
What does it mean to age? Deterioration over time! This can include; weakness, susceptibility to disease, loss of mobility and agility. The reduced ability.
Menopause Case Studies Interprofessional version
Contraception in the over 40s Ruth Adams Clinical Educator Leicester Sexual Health.
Menopause scenarios. Anita 44yrs, 1 daughter age 6, trying to conceive for 2 years. Periods now irregular, every 6-10/52 Says she’s is under ‘pressure’
Menopause Take good care of our ladies!. What is Menopause? Menopause is a normal part of life, just like puberty. 9 月是全国妇女更年期认 知月 (National Menopause.
Hormone Replacement Therapy – An Insight!
HORMONE REPLACEMENT THERAPY (HRT) Evidence-based Guidelines Dr Mahdy El- Mazzahy Damietta general Hospital 7 th International Annual Congress “Alexandria”
M E N O P A U S E King Khalid University Hospital Department of Obstetrics & Gynecology Course 482.
Herbal way to relieve menopausal symptoms Natural remedies for menopause We often hear women talking about middle-aged menopausal and menopausal symptoms.
Hormone Replacement Therapy
Contraception in the over 40’s
MENOPAUSE.
Mammograms and Breast Exams: When to start /stop mammograms
Managing Menopausal Symptoms after Breast Cancer Rod Baber
Endometrial cancer on the rise in older women (August 2014)
Contraception in the over 40’s
Impact of Oestrogen Therapy on Diabetes and Vascular Risk
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
Chapter 61 Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications 1.
Women’s Health Dr Emma Broughton GPwSI
Menopause Update Dr Fiona Jacklin April 2018
The Menopause What is it? What are the common symptoms?
PHARMACOTHERAPY II PHCY 410
GP Education Meeting September 2018
Hormone Replacement Therapy (HRT)
Menopausal Hormone Replacement Therapy and Genital And Breast Cancers
Hormone replacement therapy
Postmenopausal reproductive health
Presentation transcript:

IS HRT SAFE? Rosol Hamid Consultant O&G

NO

What is safe? Driving Swimming Crossing the street Cycling Riding a motor bike Parachute jumping Flying

Evolution & controversy Over 20 years HRT changed from being the elixir of youth to being considered extremely risky

British Menopause society& Women Health Concern recommendations 2013 Informed choice Annual evaluation HRT before 60 has a favourable benefit/ risk profile Premature menopause encourage HRT until natural age of menopause Over 60 use low dose /transdermal

Effects of HRT ~Estrogen is most effective for vaso motor symptoms ~improve mood in early menopause ~ improve sexual function ~ improve vaginal dryness and dyspareunia ~ help relief bladder symptoms and reduce risk of recurrent UTI

Other effects Protective effect against connective tissue loss Bone protection Mirena can be used to reduce progesterone effects

Long term effects of HRT Preserve bone density Significant reduction in heart disease Improvement in cognition Reduction in long term risk of Alzheimer's and all cause dementia

What about breast cancer? WHI... Small increase in breast cancer risk. 1 extra case/1000 women / year. In same WHI Estrogen alone significant decrease in breast cancer risk Recent critique of both WHI and MWS revealed flaws which limit the ability of the trials to establish causation

Other cancers Conflicting evidence on ovarian cancer risk Reduced risk for endometrial on continuous combined preparations. Reduce risk of colorectal cancer

Summary practice points Individualised decision for each woman Dosage and duration individualised Annual evaluation of pros and cons With time increased sophistication of hormonal preparations will reduce side effects

Key recommendations Main indication is relief of vaso motor symptoms Duration should not be subject to arbitrary limits Routine advise on diet and life style Phytoestrogens offer some benefits on symptoms and on skeletal and cardiovascular systems Don't start HRT 10 years after menopause

Issues MPA is associated with higher risk of breast cancer than other progestogens ( American association of cancer research) Moderate increased risk of VTE may only relate to oral and not transdermal preparations (RCOG)

Does HRT cause breast cancer Recent decrease in incidence of breast cancer The decline occurred immediately as HRT use declined No duration lag to support the association The evidence neither supports nor refutes the theory of possible causation The associated risk of breast cancer is lower than that associated with obesity and alcohol and later reproduction

Benefits Re examining the evidence Reduction in cardiovascular problems Fewer risks than initially reported Neuroprotective with preservation of cognitive ability and verbal memory

Parkinson disease Younger age of onset in males Oestrogen has direct effect on dopaminergic functioning PD more common in women after surgical menopause May be protective from PD or has ameliorative effects on symptoms

Reviewing the evidence Dec 2014 HRT is the most effective treatment for menopausal symptoms In particular for younger women at the onset of menopause Hot flushes and night sweats affect 70% of women for up to 5 yrs 10% may continue for many years

The evidence Symptoms vary. In some can be debilitating and can affect quality of life HRT is the treatment for the menopause. WHI 2003 reported increased risk of breast cancer, VTE and stroke The re-analysis of the Women Health Initiative study in 2007 demonstrated that giving HRT for up to 10 years had fewer risks! And reduction in cardiovascular problems.

The evidence The Million women study 2001 suggested increased risk of breast cancer But failed to address short use to relief symptoms Women can gain the advantage and tailor treatment to reduce risk

Conclusion Women live long beyond the age of menopause Future….Improved formula with better long term benefits and reduced risks Quality of life